SenesTech: Glenbrook Capital Management reports 32.2% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SenesTech, Inc. (SNES) is the subject of Glenbrook Capital Management's Schedule 13D amendment, which reports that Glenbrook beneficially owns 2,196,973 common shares, or 32.2%, with shared voting and dispositive power. The percentage is based on 6,823,881 shares outstanding as of November 12, 2026.
Glenbrook intends to continue discussions with SenesTech's board and management and may request to inspect company books and records under Section 220 of the Delaware General Corporation Law. It has not determined whether to nominate director candidates, solicit proxies or submit a stockholder proposal.
Glenbrook says it supports JoAnna Abrams's appointment to the SenesTech board, effective November 16, 2026. Abrams is Mindclick's founder and chief executive officer; Glenbrook reports holding approximately 5% of Mindclick's outstanding equity and a Mindclick convertible note. Glenbrook says it has no agreement with Abrams regarding her board service or SenesTech securities.
Filing Explained
SenesTech reports it sold about 1.3 million shares through its at-the-market program after quarter-end, increasing shares outstanding by about 25% at an average
Key Figures
Key Terms
beneficially owned financial
at-the-market offering program financial
minimum bid price requirement regulatory
Section 220 of the Delaware General Corporation Law regulatory
convertible note financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did SenesTech report about its Nasdaq bid-price notice and ATM sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.